05.02.2013 • News

Sinopec to Sell $3.1 Billion in New Stock

China Petroleum & Chemical Corp (Sinopec), Asia's largest refiner, said it plans to raise about $3.1 billion in a share offering to fund its business development, sending its shares sharply lower as investors fretted about the volume of new stock in the market.

Sinopec agreed to sell 2.85 billion new Hong Kong-traded shares at HK$8.45 each, a 9.5% discount to Monday's close and 7.4% below the average closing price over the past 30 days, the company said in a filing to the Hong Kong stock exchange late on Monday..

The shares were sold to a group of about 10 investors that included some of the world's largest institutional investors and global fund managers, a source familiar with the transaction told Reuters.

Sinopec said in its filing that the deal would help the company "enrich its shareholder base by attracting a number of high caliber investors to participate in the placing." It gave no further description of the buyers.

Proceeds from the offering would be used "as general working capital to fund the business development of the company," Sinopec said.

The refiner has been looking to buy overseas assets from its parent Sinopec Group to boost oil and gas production. Fu Chengyu, chairman of Sinopec Group, said last year Sinopec could raise funds from the market to help fund those acquisitions.

Goldman Sachs acted as sole global coordinator and bookrunner for the deal.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.